Investment Thesis
SRx Health Solutions exhibits critically unsustainable unit economics with $6.2M revenue unable to support ~$11M operating expenses, generating -$9.6M free cash flow annually. At current burn rates, the company's $20.5M cash position provides only ~2 years of runway without dramatic operational turnaround or capital infusion.
Strengths
- Zero long-term debt eliminates refinancing and debt service risks
- Current cash position of $20.5M provides near-term operational runway
- Gross margin of 37.3% suggests underlying product economics may be viable if scale achieved
Risks
- Negative free cash flow of -$9.6M is unsustainable and depletes cash reserves at ~2-year runway
- Revenue of $6.2M cannot support $11.2M in operating expenses, indicating fundamental business model failure
- Operating loss of -$5.6M and net margin of -240.1% demonstrate severe profitability collapse
- ROE of -82.0% and ROA of -34.6% show value destruction across all shareholder/asset metrics
- Minimal insider activity (2 Form 4 filings in 90 days) suggests lack of insider confidence
- Capital requirements appear to exceed cash reserves without significant revenue inflection
Key Metrics to Watch
- Quarterly revenue growth trajectory - needs inflection to extend runway
- Operating cash flow improvement - most critical indicator of sustainability
- Operating expense reduction - cost structure must align with revenue base
- Cash balance depletion rate - tracks path to potential insolvency
- Any debt issuance or capital raise announcements indicating liquidity pressure
Financial Metrics
Revenue
6.2M
Net Income
-15.0M
EPS (Diluted)
$-0.09
Free Cash Flow
-9.6M
Total Assets
43.4M
Cash
20.5M
Profitability Ratios
Gross Margin
37.3%
Operating Margin
-89.8%
Net Margin
-240.1%
ROE
-82.0%
ROA
-34.6%
FCF Margin
-153.0%
Balance Sheet & Liquidity
Current Ratio
1.72x
Quick Ratio
1.64x
Debt/Equity
0.00x
Debt/Assets
57.8%
Interest Coverage
-8.93x
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-23T09:26:50.846199 |
Data as of: 2026-03-31 |
Powered by Claude AI